Potassium Glutamate Injection

When liver function is severely damaged, ammonia metabolism in the body is disordered, leading to hepatic coma. After intravenous infusion, this product can combine with excess ammonia in the blood to form non-toxic glutamine, which dissociates ammonia through the action of glutaminase in the kidneys and is excreted in the urine, thus alleviating the symptoms of hepatic coma. This product also participates in brain protein metabolism and sugar metabolism, promotes the oxidation process, and improves the function of the central nervous system.

Glutamate.

This product is a colorless or almost colorless clear liquid.

Used for hepatic encephalopathy, hepatic coma and other mental symptoms caused by excessive blood ammonia.

Treatment of hepatic coma: intravenous drip: dissolve 18.9 g of potassium glutamate in 500-1000 ml of 5% or 10% glucose injection and drip slowly

1. When a large amount of sodium glutamate is used to treat hepatic encephalopathy, it can cause severe alkalosis and hypokalemia due to excessive absorption of sodium. Therefore, electrolyte concentrations must be closely monitored during treatment. 2. If the infusion is too fast, symptoms such as drooling, blushing, and vomiting may occur. 3. Precursors of allergies may include facial flushing, headache, and chest tightness. 4. Children may have tremors. 5. Patients with anxiety may experience syncope, tachycardia, and nausea after use.

Overdose of this product may cause alkalemia, so it should be used with caution or prohibited in patients with alkalemia.

Not yet clear

Keep away from light and store in a sealed container.

20ml:6.3g

Zhejiang Jianfeng Pharmaceutical Co., Ltd.

• Founded in:

  1998-12-31

• Address:

  2nd Floor, Office Quality Inspection Building, Building X02, No. 58, Gaofan Section, Baitang Xiaxian, Wucheng District, Jinhua City, Zhejiang Province

• Tax NO.:

  913307017125704667

• Registered Funds:

  298.53 million yuan

• Website:

  Log in to view

• Email:

  Log in to view